Financial Ratios ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd
Stocks
603976
CNE100002W50
Non-Paper Containers & Packaging
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.90 CNY | -3.07% |
|
-6.46% | +33.99% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.42 | 2.1 | 1.57 | 2.18 | 0.85 | |||||
Return on Total Capital | 5.4 | 2.56 | 1.92 | 2.63 | 0.99 | |||||
Return On Equity % | 9.66 | 5.51 | 3.36 | 4.37 | 1.56 | |||||
Return on Common Equity | 9.66 | 5.51 | 3.36 | 4.37 | 1.56 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.9 | 19.25 | 15.72 | 18.37 | 16.25 | |||||
SG&A Margin | 7.4 | 7.22 | 6.34 | 7.18 | 8.33 | |||||
EBITDA Margin % | 22.88 | 19.13 | 17.34 | 22.97 | 19.97 | |||||
EBITA Margin % | 14.72 | 8.48 | 5.77 | 8.83 | 4.11 | |||||
EBIT Margin % | 14.59 | 8.35 | 5.65 | 8.7 | 3.95 | |||||
Income From Continuing Operations Margin % | 13.38 | 8.13 | 4.47 | 6.65 | 2.85 | |||||
Net Income Margin % | 13.38 | 8.13 | 4.47 | 6.65 | 2.85 | |||||
Net Avail. For Common Margin % | 13.38 | 8.13 | 4.47 | 6.65 | 2.85 | |||||
Normalized Net Income Margin | 8.9 | 4.33 | 2.67 | 4.57 | 1.3 | |||||
Levered Free Cash Flow Margin | -1.83 | -34.36 | 6.96 | -2.19 | 12.54 | |||||
Unlevered Free Cash Flow Margin | -0.81 | -32.82 | 8.43 | -0.56 | 14.55 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.49 | 0.4 | 0.44 | 0.4 | 0.34 | |||||
Fixed Assets Turnover | 1.31 | 1.01 | 0.98 | 0.9 | 0.81 | |||||
Receivables Turnover (Average Receivables) | 3.03 | 2.43 | 2.38 | 2.09 | 1.88 | |||||
Inventory Turnover (Average Inventory) | 3.5 | 3.22 | 3.73 | 2.92 | 2.31 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.04 | 2.55 | 2.77 | 3.24 | 4.72 | |||||
Quick Ratio | 2.51 | 1.92 | 2.22 | 2.29 | 3.66 | |||||
Operating Cash Flow to Current Liabilities | 0.28 | 0.1 | 0.51 | 0.42 | 0.61 | |||||
Days Sales Outstanding (Average Receivables) | 120.59 | 150.49 | 153.31 | 174.9 | 193.77 | |||||
Days Outstanding Inventory (Average Inventory) | 104.25 | 113.52 | 97.76 | 125.27 | 157.72 | |||||
Average Days Payable Outstanding | 136.2 | 158.55 | 149.21 | 143.43 | 147.09 | |||||
Cash Conversion Cycle (Average Days) | 88.64 | 105.45 | 101.85 | 156.73 | 204.4 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.18 | 38.86 | 36.73 | 35.32 | 37.01 | |||||
Total Debt / Total Capital | 27.1 | 27.98 | 26.87 | 26.1 | 27.01 | |||||
LT Debt/Equity | 32.87 | 33.76 | 34.25 | 35.31 | 37 | |||||
Long-Term Debt / Total Capital | 23.96 | 24.31 | 25.05 | 26.1 | 27.01 | |||||
Total Liabilities / Total Assets | 40.53 | 41.02 | 40.5 | 37.48 | 36.62 | |||||
EBIT / Interest Expense | 8.89 | 3.39 | 2.39 | 3.33 | 1.23 | |||||
EBITDA / Interest Expense | 13.96 | 7.78 | 7.36 | 8.8 | 6.24 | |||||
(EBITDA - Capex) / Interest Expense | 3.45 | -6.3 | 3.13 | 5.36 | 4.97 | |||||
Total Debt / EBITDA | 2.37 | 3.01 | 2.85 | 2.34 | 3.36 | |||||
Net Debt / EBITDA | -1.17 | 0.58 | 0.06 | 0.99 | -0.27 | |||||
Total Debt / (EBITDA - Capex) | 9.62 | -3.73 | 6.72 | 3.85 | 4.21 | |||||
Net Debt / (EBITDA - Capex) | -4.73 | -0.72 | 0.13 | 1.63 | -0.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 58.7 | -0.06 | 13.12 | -11.05 | -17.07 | |||||
Gross Profit, 1 Yr. Growth % | 85.82 | -22.74 | -7.58 | 3.93 | -25.64 | |||||
EBITDA, 1 Yr. Growth % | 85.95 | -16.78 | 2.33 | 17.75 | -27.92 | |||||
EBITA, 1 Yr. Growth % | 155.14 | -42.74 | -23.51 | 35.8 | -61.39 | |||||
EBIT, 1 Yr. Growth % | 161.1 | -42.93 | -23.52 | 36.96 | -62.31 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 100.95 | -39.25 | -37.83 | 32.24 | -64.5 | |||||
Net Income, 1 Yr. Growth % | 100.95 | -39.25 | -37.83 | 32.24 | -64.5 | |||||
Normalized Net Income, 1 Yr. Growth % | 106.81 | -51.37 | -30.27 | 52.12 | -76.31 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 102.86 | -39.44 | -37.21 | 29.63 | -62.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 31.99 | 19.16 | 11.92 | -8.38 | -7.13 | |||||
Inventory, 1 Yr. Growth % | 25.93 | 9.93 | -5.87 | 27.06 | -8.02 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 20.43 | 36.64 | 1.06 | -6.51 | -9.01 | |||||
Total Assets, 1 Yr. Growth % | 48.01 | 2.41 | 1.75 | -4.21 | -2.82 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.46 | 1.75 | 2.84 | 0.76 | -1.45 | |||||
Common Equity, 1 Yr. Growth % | 12.07 | 1.56 | 2.64 | 0.65 | -1.49 | |||||
Cash From Operations, 1 Yr. Growth % | -13.82 | -63.39 | 405.37 | -42.23 | 21.65 | |||||
Capital Expenditures, 1 Yr. Growth % | -21.8 | 100.72 | -67.41 | -20 | -62.36 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -79.12 | 1.8K | -122.9 | -128.04 | -574.35 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -90.79 | 4.09K | -129.06 | -105.89 | -2.26K | |||||
Dividend Per Share, 1 Yr. Growth % | 755.56 | -80.52 | 233.33 | 73 | -16.18 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 23.65 | 25.94 | 6.33 | 0.31 | -14.11 | |||||
Gross Profit, 2 Yr. CAGR % | 18.68 | 19.82 | -15.5 | -1.99 | -12.69 | |||||
EBITDA, 2 Yr. CAGR % | 30.53 | 24.65 | -7.62 | 9.81 | -7.87 | |||||
EBITA, 2 Yr. CAGR % | 43.55 | 21.24 | -33.65 | 2.04 | -27.58 | |||||
EBIT, 2 Yr. CAGR % | 44.58 | 22.23 | -33.93 | 2.34 | -28.15 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.14 | 10.49 | -38.54 | -9.33 | -31.48 | |||||
Net Income, 2 Yr. CAGR % | 32.14 | 10.49 | -38.54 | -9.33 | -31.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | 28.66 | 0.26 | -41.73 | 3 | -39.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 33.23 | 10.84 | -38.33 | -9.78 | -30.61 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.79 | 25.41 | 15.48 | 1.26 | -7.75 | |||||
Inventory, 2 Yr. CAGR % | 14.36 | 17.66 | 1.73 | 9.36 | 8.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 29.99 | 28.28 | 17.51 | -2.8 | -7.77 | |||||
Total Assets, 2 Yr. CAGR % | 25.69 | 23.11 | 2.08 | -1.27 | -3.52 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.34 | 6.97 | 2.29 | 1.8 | -0.35 | |||||
Common Equity, 2 Yr. CAGR % | 6.09 | 6.69 | 2.1 | 1.64 | -0.43 | |||||
Cash From Operations, 2 Yr. CAGR % | 37.81 | -43.83 | 36.02 | 70.86 | -16.17 | |||||
Capital Expenditures, 2 Yr. CAGR % | 10.99 | 25.29 | -19.12 | -48.94 | -45.13 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 152.23 | 97.83 | 108.51 | -74.66 | 15.33 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 67.3 | 93.59 | 248.93 | -86.92 | 12.82 | |||||
Dividend Per Share, 2 Yr. CAGR % | -2.5 | 29.1 | -19.42 | 140.14 | 20.42 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.17 | 15.18 | 21.51 | 0.19 | -5.86 | |||||
Gross Profit, 3 Yr. CAGR % | 5.15 | 2.85 | 9.88 | -9.46 | -11.02 | |||||
EBITDA, 3 Yr. CAGR % | 12.53 | 12.49 | 16.8 | 0.19 | -4.56 | |||||
EBITA, 3 Yr. CAGR % | 13.27 | 5.89 | 4.16 | -15.69 | -26.19 | |||||
EBIT, 3 Yr. CAGR % | 13.44 | 6.15 | 4.55 | -15.76 | -26.64 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 8.8 | 1.98 | -8.78 | -20.66 | -33.67 | |||||
Net Income, 3 Yr. CAGR % | 8.8 | 1.98 | -8.78 | -20.66 | -33.67 | |||||
Normalized Net Income, 3 Yr. CAGR % | 6.85 | -6.99 | -11.13 | -19.77 | -36.9 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.88 | 2.44 | -8.29 | -21 | -32.88 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.64 | 14.87 | 20.74 | 6.91 | -1.61 | |||||
Inventory, 3 Yr. CAGR % | 17.3 | 12.87 | 9.23 | 9.55 | 3.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 25.13 | 32.17 | 18.48 | 8.89 | -4.91 | |||||
Total Assets, 3 Yr. CAGR % | 20.29 | 17.39 | 15.54 | -0.06 | -1.79 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.99 | 4.79 | 5.58 | 1.78 | 0.7 | |||||
Common Equity, 3 Yr. CAGR % | 5.71 | 4.56 | 5.32 | 1.62 | 0.59 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.75 | -11.41 | 16.83 | 2.24 | 52.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | 25.74 | 35.23 | -20.03 | -19.42 | -53.88 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 121.21 | 392.22 | -3.59 | 6.83 | -32.72 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 68.25 | 384.76 | 2.89 | -10.49 | -28.22 | |||||
Dividend Per Share, 3 Yr. CAGR % | 56.73 | -43 | 77.11 | 3.95 | 69.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.13 | 9.37 | 8.62 | 8.98 | 5.77 | |||||
Gross Profit, 5 Yr. CAGR % | 6.21 | -1 | -3.66 | 0.89 | 0.22 | |||||
EBITDA, 5 Yr. CAGR % | 10.31 | 2.15 | 4.07 | 11.46 | 6.24 | |||||
EBITA, 5 Yr. CAGR % | 7.84 | -6.74 | -8.44 | 4.44 | -9.89 | |||||
EBIT, 5 Yr. CAGR % | 7.83 | -6.88 | -8.57 | 4.61 | -10.02 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.62 | -4.65 | -13.42 | -2.7 | -18.65 | |||||
Net Income, 5 Yr. CAGR % | 8.62 | -4.65 | -13.42 | -2.7 | -18.65 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.17 | -10.79 | -16.17 | -3.09 | -24.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.7 | -7.93 | -13.26 | -2.64 | -17.97 | |||||
Accounts Receivable, 5 Yr. CAGR % | 15.03 | 16.25 | 12.55 | 9.22 | 8.42 | |||||
Inventory, 5 Yr. CAGR % | 21.05 | 14.12 | 10.8 | 11.45 | 8.78 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.64 | 24.77 | 22.02 | 16.88 | 7.19 | |||||
Total Assets, 5 Yr. CAGR % | 25.85 | 13.59 | 12.64 | 9.54 | 7.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 18.34 | 4.35 | 4.5 | 3.58 | 3.16 | |||||
Common Equity, 5 Yr. CAGR % | 17.75 | 4.42 | 4.25 | 3.38 | 2.98 | |||||
Cash From Operations, 5 Yr. CAGR % | 32.48 | -7.21 | 24.74 | 15.21 | 2.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | 72.97 | 46.76 | 5.39 | -8.41 | -31.21 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -30.46 | 74.53 | 115.49 | 50.25 | 3.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -41 | 72.61 | 123.94 | 14.29 | 6.75 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.14 | -28.83 | 20.11 | 1.32 | 51.78 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















